A new global study has identified striking inequalities in disability caused by COVID-19 during 2020–2021, offering an early warning signal for the ongoing risk of long COVID in the years that followed — and even today. By examining across 920 locations worldwide, researchers found that low- and middle-income countries (LMICs), especially in Sub-Saharan Africa, showed disproportionately high rates of nonfatal COVID-related health loss. These findings highlight potentially hidden vulnerabilities and call for urgent action to address long-term pandemic effects in underserved populations.

Bar-Ilan University has joined a major new €8 million European initiative aimed at revolutionizing how personalized cancer treatments like CAR-T cell therapy are delivered in hospitals. Funded by the EU-backed Innovative Health Initiative (IHI), the five-year project—called EASYGEN (Easy workflow integration for gene therapy)—will develop a fully automated system that allows hospitals to manufacture CAR-T therapies on-site in just 24 hours instead of weeks.